UniProt ID | CAC1C_MOUSE | |
---|---|---|
UniProt AC | Q01815 | |
Protein Name | Voltage-dependent L-type calcium channel subunit alpha-1C | |
Gene Name | Cacna1c | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2139 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . Cell membrane . The interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane. |
|
Protein Description | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1C gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart. The various isoforms display marked differences in the sensitivity to DHP compounds. Binding of calmodulin or CABP1 at the same regulatory sites results in opposite effects on the channel function.. | |
Protein Sequence | MVNENTRMYVPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQRKRQQYGKPKKQGGTTATRPPRALLCLTLKNPIRRACISIVEWKPFEIIILLTIFANCVALAIYIPFPEDDSNATNSNLERVEYLFLIIFTVEAFLKVIAYGLLFHPNAYLRNGWNLLDFIIVVVGLFSAILEQATKADGANALGGKGAGFDVKALRAFRVLRPLRLVSGVPSLQVVLNSIIKAMVPLLHIALLVLFVIIIYAIIGLELFMGKMHKTCYNQEGIIDVPAEEDPSPCALETGHGRQCQNGTVCKPGWDGPKHGITNFDNFAFAMLTVFQCITMEGWTDVLYWMQDAMGYELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKLREKQQLEEDLKGYLDWITQAEDIDPENEDEGMDEDKPRNMSMPTSETESVNTENVAGGDIEGENCGARLAHRISKSKFSRYWRRWNRFCRRKCRAAVKSNVFYWLVIFLVFLNTLTIASEHYNQPHWLTEVQDTANKALLALFTAEMLLKMYSLGLQAYFVSLFNRFDCFIVCGGILETILVETKIMSPLGISVLRCVRLLRIFKITRYWNSLSNLVASLLNSVRSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDEMQTRRSTFDNFPQSLLTVFQILTGEDWNSVMYDGIMAYGGPSFPGMLVCIYFIILFICGNYILLNVFLAIAVDNLADAESLTSAQKEEEEEKERKKLARTASPEKKQEVMEKPAVEESKEEKIELKSITADGESPPTTKINMDDLQPSENEDKSPHSNPDTAGEEDEEEPEMPVGPRPRPLSELHLKEKAVPMPEASAFFIFSPNNRFRLQCHRIVNDTIFTNLILFFILLSSISLAAEDPVQHTSFRNHILGNADYVFTSIFTLEIILKMTAYGAFLHKGSFCRNYFNILDLLVVSVSLISFGIQSSAINVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIVIVTTLLQFMFACIGVQLFKGKLYTCSDSSKQTEAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSIDSHTEDKGPIYNYRVEISIFFIIYIIIIAFFMMNIFVGFVIVTFQEQGEQEYKNCELDKNQRQCVEYALKARPLRRYIPKNQHQYKVWYVVNSTYFEYLMFVLILLNTICLAMQHYGQSCLFKIAMNILNMLFTGLFTVEMILKLIAFKPKGYFSDPWNVFDFLIVIGSIIDVILSETNPAEHTQCSPSMSAEENSRISITFFRLFRVMRLVKLLSRGEGIRTLLWTFIKSFQALPYVALLIVMLFFIYAVIGMQVFGKIALNDTTEINRNNNFQTFPQAVLLLFRCATGEAWQDIMLACMPGKKCAPESEPSNSTEGETPCGSSFAVFYFISFYMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWAEYDPEAKGRIKHLDVVTLLRRIQPPLGFGKLCPHRVACKRLVSMNMPLNSDGTVMFNATLFALVRTALRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVVPPAGDDEVTVGKFYATFLIQEYFRKFKKRKEQGLVGKPSQRNALSLQAGLRTLHDIGPEIRRAISGDLTAEEELDKAMKEAVSAASEDDIFRRAGGLFGNHVTYYQSDSRGNFPQTFATQRPLHINKTGNNQADTESPSHEKLVDSTFTPSSYSSTGSNANINNANNTALGRFPHPAGYSSTVSTVEGHGPPLSPAVRVQEAAWKLSSKRCHSRESQGATVNQEIFPDETRSVRMSEEAEYCSEPSLLSTDMFSYQEDEHRQLTCPEEDKREIQPSPKRSFLRSASLGRRASFHLECLKRQKDQGGDISQKTALPLHLVHHQALAVAGLSPLLQRSHSPTTFPRPCPTPPVTPGSRGRPLRPIPTLRLEGAESSEKLNSSFPSIHCSSWSEETTACSGSSSMARRARPVSLTVPSQAGAPGRQFHGSASSLVEAVLISEGLGQFAQDPKFIEVTTQELADACDMTIEEMENAADNILSGGAQQSPNGTLLPFVNCRDPGQDRAVAPEDESCAYALGRGRSEEALADSRSYVSNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
63 | Ubiquitination | IDAARQAKLMGSAGN HHHHHHHHHHCCCCC | 30.57 | - | |
72 | Phosphorylation | MGSAGNATISTVSST HCCCCCCEEEECCCH | 21.33 | 26239621 | |
77 | Phosphorylation | NATISTVSSTQRKRQ CCEEEECCCHHHHHH | 27.96 | 23737553 | |
78 | Phosphorylation | ATISTVSSTQRKRQQ CEEEECCCHHHHHHH | 24.99 | 23737553 | |
79 | Phosphorylation | TISTVSSTQRKRQQY EEEECCCHHHHHHHH | 25.53 | 23737553 | |
106 | S-palmitoylation | RPPRALLCLTLKNPI CCCCEEEHHCCCCHH | 2.58 | 28680068 | |
153 | N-linked_Glycosylation | PFPEDDSNATNSNLE CCCCCCCCCCCCHHH | 58.75 | - | |
171 | Phosphorylation | YLFLIIFTVEAFLKV HHHHHHHHHHHHHHH | 13.66 | - | |
328 | N-linked_Glycosylation | GHGRQCQNGTVCKPG CCCCCCCCCCCCCCC | 56.58 | - | |
469 | Phosphorylation | RNMSMPTSETESVNT CCCCCCCCCCCCCCC | 36.33 | 22817900 | |
471 | Phosphorylation | MSMPTSETESVNTEN CCCCCCCCCCCCCCC | 33.07 | 22817900 | |
473 | Phosphorylation | MPTSETESVNTENVA CCCCCCCCCCCCCCC | 28.25 | 19060867 | |
476 | Phosphorylation | SETESVNTENVAGGD CCCCCCCCCCCCCCC | 27.12 | 22817900 | |
783 | Phosphorylation | KKLARTASPEKKQEV HHHHHHCCHHHHHHH | 32.74 | 16155576 | |
808 | Phosphorylation | EEKIELKSITADGES HHCEEEEEEECCCCC | 37.48 | 22817900 | |
810 | Phosphorylation | KIELKSITADGESPP CEEEEEEECCCCCCC | 26.28 | 22807455 | |
815 | Phosphorylation | SITADGESPPTTKIN EEECCCCCCCCCCCC | 41.53 | 25521595 | |
818 | Phosphorylation | ADGESPPTTKINMDD CCCCCCCCCCCCHHH | 44.07 | 23737553 | |
819 | Phosphorylation | DGESPPTTKINMDDL CCCCCCCCCCCHHHC | 35.38 | 23737553 | |
829 | Phosphorylation | NMDDLQPSENEDKSP CHHHCCCCCCCCCCC | 39.84 | 25338131 | |
835 | Phosphorylation | PSENEDKSPHSNPDT CCCCCCCCCCCCCCC | 39.92 | 21082442 | |
838 | Phosphorylation | NEDKSPHSNPDTAGE CCCCCCCCCCCCCCC | 54.14 | 25338131 | |
842 | Phosphorylation | SPHSNPDTAGEEDEE CCCCCCCCCCCCCCC | 37.51 | 21082442 | |
1184 | Ubiquitination | YKNCELDKNQRQCVE HHCCCCCHHHHHHHH | 68.55 | - | |
1388 | N-linked_Glycosylation | VFGKIALNDTTEINR HHHHHHCCCCCCCCC | 35.24 | - | |
1439 | N-linked_Glycosylation | APESEPSNSTEGETP CCCCCCCCCCCCCCC | 64.76 | - | |
1487 | Phosphorylation | DYLTRDWSILGPHHL HHHHCCCHHCCHHHH | 16.54 | 20479240 | |
1509 | Ubiquitination | AEYDPEAKGRIKHLD HHCCHHCCCCCCCHH | 47.24 | - | |
1545 | Phosphorylation | VACKRLVSMNMPLNS HHHHHHHHCCCCCCC | 14.72 | 20479240 | |
1635 | Acetylation | FRKFKKRKEQGLVGK HHHHHHHHHHCCCCC | 64.37 | 11789845 | |
1642 | Ubiquitination | KEQGLVGKPSQRNAL HHHCCCCCHHHHHHH | 33.73 | - | |
1644 | Phosphorylation | QGLVGKPSQRNALSL HCCCCCHHHHHHHHH | 45.30 | 27742792 | |
1650 | Phosphorylation | PSQRNALSLQAGLRT HHHHHHHHHHHHHHH | 18.94 | 23737553 | |
1670 | Phosphorylation | PEIRRAISGDLTAEE HHHHHHHCCCCCHHH | 25.85 | 26824392 | |
1674 | Phosphorylation | RAISGDLTAEEELDK HHHCCCCCHHHHHHH | 36.44 | 27742792 | |
1688 | Phosphorylation | KAMKEAVSAASEDDI HHHHHHHHHHCCCHH | 25.76 | 22324799 | |
1691 | Phosphorylation | KEAVSAASEDDIFRR HHHHHHHCCCHHHHH | 41.07 | 25521595 | |
1714 | Phosphorylation | VTYYQSDSRGNFPQT EEEEECCCCCCCCCC | 47.54 | 22817900 | |
1733 | Phosphorylation | RPLHINKTGNNQADT CCCEECCCCCCCCCC | 40.42 | 29899451 | |
1740 | Phosphorylation | TGNNQADTESPSHEK CCCCCCCCCCCCCCH | 41.18 | 29899451 | |
1742 | Phosphorylation | NNQADTESPSHEKLV CCCCCCCCCCCCHHH | 33.52 | 25521595 | |
1744 | Phosphorylation | QADTESPSHEKLVDS CCCCCCCCCCHHHCC | 54.26 | 23737553 | |
1756 | Phosphorylation | VDSTFTPSSYSSTGS HCCCCCCCCCCCCCC | 38.56 | 25338131 | |
1763 | Phosphorylation | SSYSSTGSNANINNA CCCCCCCCCCCCCCC | 32.62 | 25338131 | |
1799 | Phosphorylation | EGHGPPLSPAVRVQE CCCCCCCCHHHHHHH | 19.31 | 29514104 | |
1812 | Phosphorylation | QEAAWKLSSKRCHSR HHHHHHHHCCCCCCC | 30.04 | 25338131 | |
1818 | Phosphorylation | LSSKRCHSRESQGAT HHCCCCCCCCCCCCC | 41.17 | 29899451 | |
1821 | Phosphorylation | KRCHSRESQGATVNQ CCCCCCCCCCCCCCC | 32.57 | 29899451 | |
1835 | Phosphorylation | QEIFPDETRSVRMSE CHHCCCCCCCCCCCH | 35.31 | 30635358 | |
1889 | Phosphorylation | PKRSFLRSASLGRRA CCHHHHHHHHCCHHH | 25.10 | - | |
1897 | Phosphorylation | ASLGRRASFHLECLK HHCCHHHHHHHHHHH | 16.04 | 7814415 | |
1978 | Phosphorylation | LRLEGAESSEKLNSS EEECCCCCHHHHHHC | 43.17 | 26824392 | |
1979 | Phosphorylation | RLEGAESSEKLNSSF EECCCCCHHHHHHCC | 30.20 | 23737553 | |
2015 | Phosphorylation | ARRARPVSLTVPSQA HCCCCCEEEECCCCC | 22.47 | 26824392 | |
2020 | Phosphorylation | PVSLTVPSQAGAPGR CEEEECCCCCCCCCC | 28.46 | - | |
2034 | Phosphorylation | RQFHGSASSLVEAVL CCCCCCHHHHHHHHH | 26.38 | 25338131 | |
2035 | Phosphorylation | QFHGSASSLVEAVLI CCCCCHHHHHHHHHH | 35.83 | 25338131 | |
2125 | Phosphorylation | YALGRGRSEEALADS HHCCCCCCHHHHHHC | 42.48 | 26824392 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
783 | S | Phosphorylation | Kinase | CDK5 | P49615 | PSP |
1487 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
1487 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
1545 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
1545 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
1644 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
1897 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
1897 | S | Phosphorylation | Kinase | PRKACA | P27791 | GPS |
1897 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
1897 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
1897 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
1897 | S | Phosphorylation |
| 25368181 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAC1C_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRI13_MOUSE | Trim13 | physical | 21186355 | |
RYR2_MOUSE | Ryr2 | physical | 16352659 | |
CACB3_MOUSE | Cacnb3 | physical | 16787652 | |
IL16_MOUSE | Il16 | physical | 10479680 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-815, AND MASSSPECTROMETRY. |